Trimming the competition: Diet-drug maker's move could eliminate others WASHINGTON -- Consumers face a bewildering array of choices when it comes to weight-loss products.Check the shelves of almost any pharmacy and they're stocked with everything from SlimQuick Diet Pills, billed as the 'world's first...
Wonder slimming pill banned in U.S. over suicide fears available on NHS Weight-loss drug banned in the U.S.over fears it can heighten the risk of suicide has been given the go-ahead in Britain.
Acomplia will be available to overweight or obese patients who cannot take, or who have had no success with, the...
UK's healthcare watchdog clears use of Sanofi-Aventis' obesity drug Acomplia LONDON (Thomson Financial) - The UK's healthcare spending watchdog, the National Institute for Health and Clinical Excellence (NICE), has recommended the use of Sanofi-Aventis' obesity drug Acomplia.The drug has been recommended as an...
UK's healthcare watchdog clears use of Sanofi-Aventis' obesity drug Acomplia LONDON (Thomson Financial) - The UK's healthcare spending watchdog, the National Institute for Health and Clinical Excellence (NICE), has recommended the use of Sanofi-Aventis' obesity drug Acomplia.The drug has been recommended as an...
UK's healthcare watchdog clears use of Sanofi-Aventis' obesity drug Acomplia LONDON (Thomson Financial) - The UK's healthcare spending watchdog, the National Institute for Health and Clinical Excellence (NICE), has recommended the use of Sanofi- (News/Aktienkurs) Aventis' obesity drug Acomplia.The drug has been...
UK's healthcare watchdog clears use of Sanofi-Aventis' obesity drug Acomplia LONDON (Thomson Financial) - The UK's healthcare spending watchdog, the National Institute for Health and Clinical Excellence (NICE), has recommended the use of Sanofi-Aventis' obesity drug Acomplia.The drug has been recommended as an...
UK's healthcare watchdog clears use of Sanofi-Aventis' obesity drug Acomplia LONDON (Thomson Financial) - The UK's healthcare spending watchdog, the National Institute for Health and Clinical Excellence (NICE), has recommended the use of Sanofi-Aventis' obesity drug Acomplia.The drug has been recommended as an...
Sanofi obesity drug gets final okay from UK's NICE -0400 (Reuters Health) LONDON (Reuters) - Sanofi-Aventis won a final green light for its obesity drug Acomplia from Britain's cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health...
Controversial obesity drug gets final okay Sanofi-Aventis won a final green light for its obesity drug Acomplia from cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health service.Font Scale:A A A Sanofi-Aventis won a final...
NHS approval for weight-loss drug A controversial weight-loss drug has been approved for use by the NHS despite concerns over psychological side effects.Rimonabant was launched in 2006 and last month the Medicines and Healthcare products Regulatory Agency (MHRA) reported...
Controversial obesity drug gets final okay Reuters - 2 hours 7 minutes ago LONDON (Reuters) - Sanofi-Aventis won a final green light for its obesity drug Acomplia from cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health...
UK's healthcare watchdog clears use of Sanofi-Aventis' obesity drug Acomplia LONDON (Thomson Financial) - The UK's healthcare spending watchdog, the National Institute for Health and Clinical Excellence (NICE), has recommended the use of Sanofi-Aventis' obesity drug Acomplia.The drug has been recommended as an...
Glaxosmithkline's Weight-Loss Drug Disappoints as Expected About a year ago, I wrote about Glaxosmithkline's (GSK) attempt to sell the lipase inhibitor orlistat over the counter as Alli: 'So my forecast for Alli is strong sales - for a while.Then it takes a dive, never to scale those heights...
Alli: 'Underwhelming' About a year ago, I wrote about GSK's attempt to sell the lipase inhibitor orlistat over the counter as Alli: 'So my forecast for Alli is strong sales - for a while.Then it takes a dive, never to scale those heights again, as the word...
A Drug With Efficacy Superior to That of Xenical at Inducing Weight Loss Would Earn a 40 Percent Patient Share Advantages in Efficacy and Delivery Will Make Qnexa the New Clinical Gold Standard Drug by 2011, According to a New Report from Decision Resources WALTHAM, Mass., June 12, 2008 /PRNewswire/ -- Decision Resources, one of the world's leading...
Glaxo: 4M people tried diet drug since launchNEW YORK - The only over-the-counter, federally approved weight l NEW YORK - The only over-the-counter, federally approved weight loss pill in the U.S.isn't exactly flying off shelves, but it's not because Americans are getting any slimmer.
GlaxoSmithKline said Wednesday that 4 million people have...
First-year sales of GSK's Alli 'underwhelming,' analyst says Although four million people have tried GlaxoSmithKline's OTC weight loss drug Alli during its first year on the market, preliminary sales figures are pretty underwhelming, one analyst tells the Associated Press.WBB Securities analyst...
Glaxo: 4M people tried diet drug since launch NEW YORK The only over-the-counter, federally approved weight loss pill in the U.S.isn't exactly flying off shelves, but it's not because Americans are getting any slimmer.
GlaxoSmithKline said Wednesday that 4 million people have tried...
Glaxo: 4M people tried diet drug since launch NEW YORK - The only over-the-counter, federally approved weight loss pill in the U.S.isn't exactly flying off shelves, but it's not because Americans are getting any slimmer.
GlaxoSmithKline said Wednesday that 4 million people have...
Glaxo: 4M people tried diet drug since launchNEW YORK - The only over-the-counter, federally approved weight l NEW YORK - The only over-the-counter, federally approved weight loss pill in the U.S.isn't exactly flying off shelves, but it's not because Americans are getting any slimmer.
GlaxoSmithKline said Wednesday that 4 million people have...
Glaxo: 4M people tried diet drug since launch Story highlightsThe only over-the-counter, federally approved weight loss pill in the U.S.isn't exactly flying off shelves, but it's not because Americans are getting any slimmer.
NEW YORK The only over-the-counter, federally approved...
Glaxo: 4M people tried diet drug since launch The only over-the-counter, federally approved weight loss pill in the U.S.isn't exactly flying off shelves, but it's not because Americans are getting any slimmer.
GlaxoSmithKline said Wednesday that 4 million people have tried alli...
Glaxo: 4M people tried diet drug since launch The only over-the-counter, federally approved weight loss pill in the U.S.isn't exactly flying off shelves, but it's not because Americans are getting any slimmer.
GlaxoSmithKline said Wednesday that 4 million people have tried alli...
Slow sales for Glaxo diet drug New York (AP) - The only over-the-counter weight loss pill in the U.S.isn't exactly flying off shelves, but it's not because Americans are getting any slimmer.
GlaxoSmithKline said Wednesday that 4 million people have tried alli since...
Glaxo: 4M people tried diet drug since launch The only over-the-counter, federally approved weight loss pill in the U.S.isn't exactly flying off shelves, but it's not because Americans are getting any slimmer.
GlaxoSmithKline said Wednesday that 4 million people have tried alli...
